For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Cognizant Technology Solutions Corporation (CTSH) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-11): Designation Watch · Cairn score +31 (−100…+100 Quality+Value blend) · Quality 36 · Value 27 · Sentiment -3 (timing only, not weighted) · Composite fair value $68.87 vs $55.39 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Cognizant Technology Solutions Corporation is a global professional services and technology company headquartered in Teaneck, New Jersey, founded in 1994. The company focuses on helping enterprises modernize their technology stacks, become data-enabled, and apply artificial intelligence to improve decision-making and operations. Cognizant provides consulting, systems integration, application development and maintenance, cloud migration, digital engineering, and business process services to clients across industries such as financial services, healthcare, life sciences, manufacturing, retail, and communications. It plays a significant role in large-scale digital transformation programs, including modernizing legacy systems, implementing cloud and SaaS platforms, and optimizing processes through automation and analytics. By combining domain expertise with technology capabilities, Cognizant serves as a strategic partner to corporations and institutions seeking to enhance efficiency, improve customer experience, and manage complex IT and operational environments in an increasingly digital and AI-driven market.
Earnings Schedule
Checked daily · calendar updated Aug 11| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | $1.38 | $1.37 -0.7% | — | — |
| Apr 29, 2026 | $1.33 | $1.40 +5.3% | — | — |
| Mar 20, 2026 | $-0.18 | $-0.15 +16.7% | — | — |
| Mar 11, 2026 | $-1.30 | $-1.72 -32.3% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Recent SEC Filings
| Filed | Form | Document |
|---|---|---|
| Aug 5, 2026 | 4 | View |
| Aug 5, 2026 | 4 | View |
| Aug 3, 2026 | 144 | View |
| Aug 3, 2026 | 144 | View |
| Jul 29, 2026 | 10-Q | View |
| Jul 29, 2026 | 8-K | View |
| Jul 17, 2026 | SCHEDULE 13G | View |
| Jul 15, 2026 | SCHEDULE 13G | View |
| Jul 10, 2026 | 8-K | View |
| Jul 6, 2026 | 4 | View |
| Jul 1, 2026 | 144 | View |
| Jun 17, 2026 | 4 | View |
Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 4.56
Total Equity: $15.02B
Shares: 489,000,000
Total Debt: $576.00M
Cash: $1.90B
EBITDA: $3.94B
Total Debt: $576.00M
Cash: $1.90B
Revenue: $21.11B
Revenue: $21.11B
Revenue: $21.11B
Total Equity: $15.02B
Tax Rate: 36.2%
Equity: $15.02B
Total Debt: $576.00M
Cash: $1.90B
Current Liabilities: $3.66B
Long-Term Debt: $543.00M
Total Debt: $576.00M
Total Equity: $15.02B
Shares: 489,000,000
Shares: 489,000,000
CapEx: -$288.00M
Shares: 489,000,000
Stock Price: $55.39
Net Income: $2.23B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 3, 2026 1:08pm (7d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $18.5B | $19.4B | $19.4B | $19.7B | $21.1B |
| Cost of Revenue | $11.6B | $12.4B | $12.7B | $13.0B | $14.0B |
| Gross Profit | $6.9B | $7.0B | $6.7B | $6.8B | $7.1B |
| Operating Expenses | $4.1B | $4.0B | $4.0B | $3.9B | $3.7B |
| Operating Income | $2.8B | $3.0B | $2.7B | $2.9B | $3.4B |
| Net Income | $2.1B | $2.3B | $2.1B | $2.2B | $2.2B |
| EBITDA | $3.4B | $3.5B | $3.2B | $3.4B | $3.9B |
| EPS | $4.06 | $4.42 | $4.21 | $4.52 | $4.57 |
| EPS (Diluted) | $4.05 | $4.41 | $4.21 | $4.51 | $4.56 |
Balance Sheet (Annual)
Last updated: Aug 3, 2026 12:43pm (7d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.8B | $2.2B | $2.6B | $2.2B | $1.9B |
| Total Current Assets | $7.3B | $7.3B | $7.5B | $7.5B | $7.8B |
| Total Assets | $17.9B | $17.9B | $18.5B | $20.0B | $20.7B |
| Current Liabilities | $3.5B | $3.3B | $3.3B | $3.6B | $3.7B |
| Long-Term Debt | $626.0M | $638.0M | $606.0M | $875.0M | $543.0M |
| Total Liabilities | $5.9B | $5.5B | $5.3B | $5.6B | $5.7B |
| Total Equity | $12.0B | $12.3B | $13.2B | $14.4B | $15.0B |
| Retained Earnings | $11.9B | $12.6B | $13.3B | $14.7B | $15.2B |
Cash Flow (Annual)
Last updated: Aug 3, 2026 1:08pm (7d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $2.6B | $2.3B | $2.1B | $2.9B |
| Capital Expenditure | -$279.0M | -$332.0M | -$317.0M | -$297.0M | -$288.0M |
| Free Cash Flow | $2.2B | $2.2B | $2.0B | $1.8B | $2.6B |
| Acquisitions (net) | -$970.0M | -$367.0M | -$409.0M | -$1.6B | $0 |
| Net Debt Issued / (Repaid) | $0 | $650.0M | $0 | $0 | — |
| Dividends Paid | -$509.0M | -$564.0M | -$591.0M | -$600.0M | -$610.0M |
| Stock Buybacks | -$771.0M | -$1.4B | -$1.1B | -$605.0M | -$1.4B |
| Net Change in Cash | -$888.0M | $502.0M | $423.0M | -$486.0M | $403.0M |
Growth Trends (YoY %)
Last updated: Aug 3, 2026 1:08pm (7d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +5.0% | -0.4% | +2.0% | +7.0% |
| Gross Profit Growth | +1.1% | -4.2% | +1.3% | +5.0% |
| Operating Income Growth | +5.0% | -9.4% | +7.5% | +17.2% |
| Net Income Growth | +7.2% | -7.2% | +5.4% | -0.4% |
| EBITDA Growth | +4.0% | -8.3% | +5.9% | +14.7% |
Dividend History (Last 20)
Last updated: Aug 3, 2026 12:43pm (7d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-08-18 | $0.33 | — | — | — |
| 2026-05-18 | $0.33 | — | — | — |
| 2026-02-18 | $0.33 | — | — | — |
| 2025-11-18 | $0.31 | — | — | — |
| 2025-08-18 | $0.31 | — | — | — |
| 2025-05-19 | $0.31 | — | — | — |
| 2025-02-18 | $0.31 | — | — | — |
| 2024-11-19 | $0.30 | — | — | — |
| 2024-08-20 | $0.30 | — | — | — |
| 2024-05-17 | $0.30 | — | — | — |
| 2024-02-16 | $0.30 | — | — | — |
| 2023-11-20 | $0.29 | — | — | — |
| 2023-08-18 | $0.29 | — | — | — |
| 2023-05-18 | $0.29 | — | — | — |
| 2023-02-16 | $0.29 | — | — | — |
| 2022-11-17 | $0.27 | — | — | — |
| 2022-08-18 | $0.27 | — | — | — |
| 2022-05-19 | $0.27 | — | — | — |
| 2022-02-17 | $0.27 | — | — | — |
| 2021-11-18 | $0.24 | — | — | — |
Insider Trading (Recent)
Last updated: Aug 3, 2026 12:53pm (7d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-03 | Kim John Sunshin | S-Sale | 2,500.00 | $57.05 | $142,625 |
| 2026-08-03 | Dalal Jatin P | S-Sale | 12,000.00 | $55.76 | $669,168 |
| 2026-07-01 | Kerdman Alina | M-OptionExercise | 207.00 | $0.00 | $0 |
| 2026-07-01 | Kerdman Alina | F-InKind | 68.00 | $38.73 | $2,634 |
| 2026-07-01 | Kerdman Alina | S-Sale | 137.00 | $39.82 | $5,455 |
| 2026-06-15 | Kerdman Alina | M-OptionExercise | 199.00 | $0.00 | $0 |
| 2026-06-15 | Kerdman Alina | F-InKind | 65.00 | $52.17 | $3,391 |
| 2026-06-15 | Kerdman Alina | S-Sale | 133.00 | $51.70 | $6,876 |
| 2026-06-15 | Dalal Jatin P | M-OptionExercise | 1,846.00 | $0.00 | $0 |
| 2026-06-15 | Dalal Jatin P | M-OptionExercise | 648.00 | $0.00 | $0 |
| 2026-06-15 | Dalal Jatin P | F-InKind | 1,346.00 | $52.17 | $70,221 |
| 2026-06-15 | Singisetti Ravi Kumar | M-OptionExercise | 5,987.00 | $0.00 | $0 |
| 2026-06-15 | Singisetti Ravi Kumar | F-InKind | 3,230.00 | $52.17 | $168,509 |
| 2026-06-15 | Diaz Kathryn | M-OptionExercise | 698.00 | $0.00 | $0 |
| 2026-06-15 | Diaz Kathryn | M-OptionExercise | 49.00 | $0.00 | $0 |
| 2026-06-15 | Diaz Kathryn | F-InKind | 372.00 | $52.17 | $19,407 |
| 2026-06-15 | Kim John Sunshin | M-OptionExercise | 1,646.00 | $0.00 | $0 |
| 2026-06-15 | Kim John Sunshin | F-InKind | 888.00 | $52.17 | $46,327 |
| 2026-06-15 | Gummadi Surya | M-OptionExercise | 1,397.00 | $0.00 | $0 |
| 2026-06-15 | Gummadi Surya | M-OptionExercise | 598.00 | $0.00 | $0 |
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Narrative Economics
market-narrative step).
Claude Reading
Reading the raw tape first: revenue has re-accelerated from ~$4.85B in Q2'24 to $5.41B in Q1'26, a run-rate approaching $21.6B annualized versus $19.74B in FY24 — that's ~7% YoY, materially above the 4.4% three-year CAGR and inconsistent with the "legacy commoditization" bear. Margins are stable in the 12% NI range except for the anomalous Q3'25 print (5.1%, $274M NI on $5.42B rev) — that's a one-time charge quarter (likely restructuring or a legal/tax item) that dragged FY25 NI to $2.23B, otherwise trailing four-quarter ex-that-quarter run-rate is closer to $2.6B. FCF of $2.60B on a $24.93B market cap is a 10.4% FCF yield, with net cash of ~$1.3B ($1.9B cash vs $576M debt) and ROIC of 15.8%. At 12x earnings and 6x EV/EBITDA, this is not priced like a growing business — it's priced like a melting ice cube.
The synthesis verdict of undervalued with fair value $68-74 is directionally right but the methods it flags as disagreeing deserve scrutiny. A DCF on $2.6B FCF growing 3-4% with a 9% discount rate gets you to roughly $37B enterprise value, or ~$82/share — above the composite. The composite is likely being dragged down by relative-multiple methods anchoring to a depressed peer set (Infosys, Wipro trade at similar multiples; only Accenture commands 20x+). So the question is whether CTSH deserves the Indian-IT multiple or the Accenture multiple. Given 15.8% ROIC, US-listed governance, and the Belcan/digital-engineering mix shift, a 15-16x multiple isn't crazy — implying $70-75. I'd put fair value at $65-72, closer to the composite than the signal-adjusted $74.
The contrarian case that actually has teeth: (1) IT services headcount is the single largest cost and AI code-generation is a genuine deflationary force on billable hours — Accenture management has already flagged pricing pressure in application development; CTSH is more exposed than Accenture given mix. (2) The "revenue acceleration" is partly Belcan acquisition inorganic — organic growth is probably 3-4%, not 7%. (3) Insider activity is net selling in dollar terms despite the "Net Insider Buying" tag — the transactions listed are option exercises immediately followed by sales, which is neutral-to-slightly-negative, not bullish. The secondary signal is misreading the pattern. (4) The Q3'25 margin collapse to 5.1% is unexplained in the data provided — if that's a recurring restructuring cadence rather than a one-off, normalized earnings are lower than the headline suggests. (5) Sector intelligence flags "in line with sector" and macro "headwinds" — enterprise IT budgets are the first thing cut in a slowdown, and the 37% drawdown from highs reflects real client-spending anxiety, not irrational selling.
Where I land: I agree with the synthesis direction (undervalued) but with lower conviction than the +34.7% upside implies. Fair value $65-70 is defensible, giving ~20-25% upside plus a 2.35% dividend — a respectable but not table-pounding setup. The narrative model's "fallen-angel, anchored, minimal intensity" framing is exactly right: this isn't a story stock, it's a cash-flow arbitrage between skeptics who think AI eats services and realists who see $2.6B of FCF regardless. The critical variable is organic revenue growth over the next 2-3 quarters — if Q2/Q3'26 prints show organic growth sustaining 4%+ with margins holding at 12%, the re-rating happens. If organic growth decelerates below 3% and margins compress toward 10%, fair value is $50-55 and you're paying full price today. The 10.4% FCF yield gives you a wide margin of safety on the downside; the upside is capped by the AI-disruption overhang until management demonstrates GenAI is accretive to their revenue base, not just their cost base. Starter position at $55 is reasonable; I'd want to add aggressively only below $48 or on evidence organic growth is holding.
GPT Reading
At $55.39, Cognizant looks cheap on almost every static multiple, but the raw operating record says the discount is mostly deserved rather than obviously mistaken. This is a $21.1B revenue services business that has spent five years barely moving: revenue was $18.5B in 2021, $19.4B in 2022, slipped to $19.35B in 2023, reached $19.74B in 2024, and only got to $21.11B in 2025. Net income tells an even flatter story: $2.14B, $2.29B, $2.13B, $2.24B, $2.23B across those same years. That is not a compounding growth engine; it is a steady annuity with some cyclical wobble. The quarterlies show a bit more life lately — Q1 2026 revenue of $5.41B was up 5.7% from $5.12B a year earlier, and the trailing four quarters sit around a $21.4B annualized run-rate — but this still looks like mid-single-digit recovery growth, not a structural re-acceleration.
The better part of the story is quality and resilience. Gross margin of 33.7%, operating margin of 16.1%, net margin of 10.6%, ROIC of 15.8%, and FCF of $2.60B on just $288M of capex are all solid for an IT services company. The balance sheet is also plainly underlevered: $1.90B of cash against only $576M of debt, current ratio 2.14, and equity of $15.0B. On enterprise value, the stock is undeniably inexpensive at about 1.1x revenue and 6.0x EBITDA. That valuation fits a business producing roughly $2.2B of annual earnings and $2.6B of FCF, and it gives investors a low-teens earnings multiple plus a 2.35% dividend yield with only a 27% payout ratio. If you want downside protection from financial fragility, Cognizant has it.
What stops me from calling it clearly undervalued is that the operating trajectory does not fully support a rerating thesis. Annual operating income improved from $2.89B in 2024 to $3.39B in 2025, but net income did not follow, staying essentially flat at $2.23B versus $2.24B. The quarterly earnings pattern also includes a glaring disruption: Q3 2025 delivered $5.42B of revenue but only $274M of net income, a 5.1% margin versus the usual 11%-13%. Maybe that was one-time, and the next two quarters normalized back to $648M and $662M of profit, but it reminds you this is not a perfectly smooth machine. More importantly, if revenue is only growing 4%-7% and earnings are mostly range-bound, a 12x P/E is not absurdly low — it may simply be the right multiple for a labor-intensive business facing pricing pressure, AI-driven delivery uncertainty, and limited evidence of sustained operating leverage.
The best argument against my caution is straightforward: the market may be anchoring too hard on old stagnation while the recent numbers show a healthier base. Revenue has gone from $4.85B in Q2 2024 to $5.41B in Q1 2026, and excluding the odd Q3 2025 hit, net income has been remarkably consistent in the mid-$600M range. On that normalized quarterly earnings power, annual EPS could support something better than 12x, especially with net cash, high cash conversion, and an EV/EBITDA multiple closer to a no-growth industrial than a strategic IT vendor. If management can hold 12%+ net margins while growing revenue high single digits, then a move toward even 14x-15x earnings would support a price in the mid-$60s. That bull case is real; I just think it requires proof that 2025 was an inflection, not another temporary bounce in an otherwise mature franchise.
What would change my mind is specific, not theoretical. If the next few quarters show revenue sustaining above $5.5B with year-over-year growth staying at 6%-8% and net income holding above $650M without another margin air pocket, I would become constructive because that would imply a cleaner $2.5B+ earnings run-rate than the annual history currently shows. Likewise, if annual FCF can stay at or above $2.6B while capital returns rise, the stock likely deserves a higher floor than today’s price. On the other hand, if revenue slips back toward the $5.1B-$5.2B range or margins revisit anything close to that 5.1% Q3 2025 level, then even $55 is not especially cheap for a business the market will read as ex-growth and structurally exposed.
Grok Reading
The numbers describe a mature cash compounder that the market has simply stopped paying up for. Cognizant generated $21.11B in 2025 revenue, up roughly 7% from $19.74B the prior year, after three years of near-flat top-line around $19.3–19.7B. Free cash flow hit $2.60B on only $288M of capex, producing a trailing FCF yield north of 10% at the $24.93B market cap. Operating margin held at 16.1% and net margin at 10.6%, with the balance sheet carrying just $576M of debt against $1.90B cash and $15.02B of equity—debt-to-equity of 0.04. At 12.1× earnings, 6.0× EV/EBITDA and 1.28× sales, the stock screens as a deep-value IT services name; the valuation synthesis fair-value band of $69–$75 implies 25–35% upside from $55.39, and that arithmetic is hard to dismiss when FCF conversion is this clean and the dividend already yields 2.35% on a 27% payout.
What stands out inside the quarterly tape is the one soft print—Q3 2025 net income collapsed to $274M (5.1% margin) before snapping back to $648–662M and 12.2% margins in the two subsequent quarters. That spike looks like a one-time charge or restructuring rather than structural margin collapse, because trailing twelve-month profitability and the full-year 2025 operating profit of $3.39B (up from $2.89B) remain intact. Revenue has marched steadily higher on a quarterly basis from $4.85B in mid-2024 to the $5.3–5.4B range recently, consistent with the 7% recent year-over-year print and the 4.4% multi-year revenue CAGR. Earnings CAGR of only 2.4% is the weaker link, but FCF CAGR of 13.5% shows the business is still throwing off incremental cash even when GAAP earnings are flat. ROIC at 15.8% and ROE at 14.9% are respectable for a labor-intensive model and do not scream secular decay.
The prior models correctly flag the company as a mature earner and a fallen-angel narrative with low cult intensity; I agree the discount is fundamentals-anchored rather than meme-driven. Where I push back is on treating the AI-disintermediation bear case as already fully priced and therefore irrelevant. The market is paying Accenture-type peers materially higher multiples precisely because those firms are perceived as AI winners; Cognizant’s 40–50% relative discount embeds a harsher verdict on its ability to defend pricing and headcount leverage. The “net insider buying” secondary signal is also overstated—the last ten filings are almost entirely option exercises followed by sell-to-cover, not open-market accumulation. And revenue-confidence notes a decelerating quarterly trend even while the year-over-year rate looks healthy, so the re-acceleration story is not yet locked in.
The strongest opposing case is straightforward: 2.4% earnings CAGR, a single-digit growth ceiling, and genuine structural risk that generative AI compresses the billable-hour model faster than Cognizant can replace it with higher-value consulting. If that path materializes, a 12× P/E and 6× EV/EBITDA are not cheap—they are appropriate for a slowly melting cash cow, and the $69–$75 fair-value targets overstate terminal growth. Margin resilience in 2025 looks good only until you notice net income was essentially unchanged ($2.23B vs $2.24B) despite $1.4B of incremental revenue; that is operating leverage going the wrong way. A smart skeptic would also note that the fortress balance sheet and 10% FCF yield are exactly what you expect in a value trap that keeps looking “cheap” while the multiple never expands.
I would reverse to a fair-value or overvalued stance if two consecutive quarters show revenue growth slipping back below 3% or operating margin compressing sustainably under 14%, confirming the AI-commoditization thesis in the numbers. Conversely, a clean print of double-digit organic growth or operating margin expansion back toward 17–18% with stable headcount would force a re-rating acknowledgment and push my target toward the upper end of the $75 zone. Until then the cash yield and balance-sheet optionality dominate.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · four lenses
Cognizant is a mature, self-funding services business: $21.1B revenue in 2025 with $2.60B FCF, $1.91B liquid cash, $1.34B net cash, and an Altman Z of 5.46. Earnings quality is genuinely clean - OCF/NI at 1.13x, accruals at -1.5% of assets, Beneish M at -2.52 - so the $2.23B of reported net income appears to be real cash economics, corroborated by FCF actually exceeding NI in 2025. Capital return discipline is a real strength: diluted share count fell from 528M to 489M (a -1.9% CAGR), SBC is a modest 0.9% of revenue, and buybacks are roughly 5x SBC, meaning per-share value is being concentrated. The soft spots are on the operating side. Gross margin has drifted down every single year from 37.3% (2021) to 33.7% (2025) - a 360bps erosion that suggests pricing pressure or unfavorable mix in a competitive IT services market. Operating margin dipped to 13.9% in 2023 before recovering to 16.1% in 2025, and revenue growth has been sluggish (roughly 3.3% CAGR over four years) with a flat 2022-2024 stretch. Net income has essentially plateaued around $2.1-2.3B for five years. Insider activity is mostly routine option-exercise-and-sell mechanics; the 'net buying' flag is small in dollar terms and not a strong signal either way.
Verify before trusting this (6)
- Segment/geographic mix and whether margin erosion is concentrated in a specific vertical or offshore pricing dynamic
- Customer concentration and top-10 client retention trends in the 10-K
- Book-to-bill and large-deal TCV disclosures to gauge forward revenue durability
- Impact and integration status of recent acquisitions (e.g., Belcan) on organic vs inorganic growth
- Attrition and utilization rates - key labor-model indicators for services quality
- Any GenAI-related productivity commentary and pricing implications in MD&A
Price is $55.33 against a composite FV of $68.87 (signal-adjusted $74.61), implying 24-35% upside. The methods cluster reasonably: DCF at $74.90 and anchored P/E at $74.10 bracket the upside case, while the EPV floor at $51.56 sits just below spot - meaning the market is pricing CTSH roughly at no-growth steady-state cash generation. Earnings quality is high (score 3), so no haircut is warranted; the Solid quality grade supports, not inflates, deserved value.
Verify before trusting this (5)
- Book-to-bill and large-deal TCV trend in latest quarter
- Digital/AI revenue mix disclosure and growth rate
- Gross margin trajectory and utilization
- Buyback pace and net share count reduction
- Management commentary on GenAI impact on headcount-linked revenue
CTSH sits in a quiet corner of the narrative universe: a fallen-angel IT services name with minimal story intensity and low cult coefficient, meaning neither bulls nor bears are pounding the tape. The active debate (digital transformation partner vs commoditized middleman being AI-disintermediated) is real but low-heat, so day-to-day sentiment pressure is muted. Recent news is actually a small positive: a Barron's piece framing Cognizant's multi-model AI partnership strategy as a differentiated angle, plus analyst coverage flagging it alongside a 'Strong Buy' cohort. That is a modest narrative upgrade from pure legacy-services skepticism toward AI-enabler optionality.
Verify before trusting this (4)
- Whether AI-partnership news flow accelerates or fizzles in coming weeks
- Accenture's next print and guide - a bad ACN read drags the whole cohort
- Any analyst target revisions post-earnings
- Client in-sourcing or AI-automation datapoints that would harden the bear narrative
This lens hasn't been run for this ticker yet.